Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
BMC Cancer|May 3, 2015
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adultsChieh-Lung Cheng, Chi-Cheng Li, Hsin-An Hou, et al.
Leukemia & Lymphoma|October 23, 2002
Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphomaChin-Lun Huang, Zhong-Zhe Lin, Ih-Jen Su, et al.
Blood Cancer Journal|April 6, 2018
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndromeHsin-An Hou, Cheng-Hong Tsai, Chien-Chin Lin, et al.
Therapeutic Advances in Hematology|March 14, 2018
Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL studyChing-Yuan Kuo, Po-Nan Wang, Wen-Li Hwang, et al.
Haematologica|September 7, 2014
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expressionYuan-Yeh Kuo, Hsin-An Hou, Yin-Kai Chen, et al.
British Journal of Haematology|March 29, 2019
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort studyJia-Hau Liu, Xiu-Wen Liao, Chien-Hung Chen, et al.
American Journal of Hematology|January 2, 2023
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus ClassificationWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Blood|November 8, 2008
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survivalTiffany Ting-Fang Shih, Hsin-An Hou, Chieh-Yu Liu, et al.
Leukemia Research|May 1, 2010
Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy eraDong-Wook Kim, Shripad D Banavali, Udomsak Bunworasate, et al.
BMC Cancer|June 26, 2019
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndromeHuai-Hsuan Huang, Fei-Yun Chen, Wen-Chien Chou, et al.
Pageof 12